133 related articles for article (PubMed ID: 18350285)
1. A reversible coma after oxaliplatin administration suggests a pathogenetic role of electrolyte imbalance.
Basso M; Cassano A; Modoni A; Spada D; Trigila N; Quirino M; Schinzari G; Barone C
Eur J Clin Pharmacol; 2008 Jul; 64(7):739-41. PubMed ID: 18350285
[No Abstract] [Full Text] [Related]
2. [Hypocalcemic hypomagnesemic coma after carboplatin].
Beuzeboc P; Deygere H; Boccaccio F; Christoforov B
Presse Med; 1989 Sep 2-9; 18(27):1343-4. PubMed ID: 2529502
[No Abstract] [Full Text] [Related]
3. Immunohemolytic anemia following oxaliplatin administration.
Garufi C; Vaglio S; Brienza S; Conti L; D'Attino RM; Girelli G; Terzoli E
Ann Oncol; 2000 Apr; 11(4):497. PubMed ID: 10847475
[No Abstract] [Full Text] [Related]
4. Anaphylaxis after oxaliplatin.
Médioni J; Coulon MA; Morere JF; Hennebelle F; Piperno-Neumann S; Breau JL
Ann Oncol; 1999 May; 10(5):610. PubMed ID: 10416017
[No Abstract] [Full Text] [Related]
5. Oxaliplatin-induced neuropathy: a tale of two electrolytes.
Babiker HM; Green MR; Nelson MA; Elquza E
Support Care Cancer; 2015 Jun; 23(6):1483-5. PubMed ID: 25801447
[No Abstract] [Full Text] [Related]
6. Renal tubular acidosis due to oxaliplatin.
Linch M; Cunningham D; Mingo O; Stiles A; Farquhar-Smith WP
Ann Oncol; 2007 Apr; 18(4):805-6. PubMed ID: 17389529
[No Abstract] [Full Text] [Related]
7. Reversible palpebral ptosis following oxaliplatin infusion.
La Verde N; Garassino MC; Spinelli G; Scanni A; Sburlati P; Farina G; Labianca R
Dig Liver Dis; 2007 Nov; 39(11):1041. PubMed ID: 17913604
[No Abstract] [Full Text] [Related]
8. Reversible posterior leukoencephalopathy syndrome associated with oxaliplatin.
Pinedo DM; Shah-Khan F; Shah PC
J Clin Oncol; 2007 Nov; 25(33):5320-1. PubMed ID: 18024878
[No Abstract] [Full Text] [Related]
9. Severe anaphylactic reactions to oxaliplatin.
Tournigand C; Maindrault-Goebel F; Louvet C; de Gramont A; Krulik M
Eur J Cancer; 1998 Jul; 34(8):1297-8. PubMed ID: 9849497
[No Abstract] [Full Text] [Related]
10. Sudden-onset thrombocytopenia with oxaliplatin.
Dold FG; Mitchell EP
Ann Intern Med; 2003 Jul; 139(2):E156. PubMed ID: 12859182
[No Abstract] [Full Text] [Related]
11. Lessons learned from hyponatremia associated with hyperthermic intraperitoneal chemoperfusion with oxaliplatin.
Nguyen MK
Perit Dial Int; 2008; 28(1):32-4. PubMed ID: 18178945
[No Abstract] [Full Text] [Related]
12. Ocular changes with oxaliplatin.
O'Dea D; Handy CM; Wexler A
Clin J Oncol Nurs; 2006 Apr; 10(2):227-9. PubMed ID: 16708705
[TBL] [Abstract][Full Text] [Related]
13. A case report of oxaliplatin extravasation.
Foo KF; Michael M; Toner G; Zalcberg J
Ann Oncol; 2003 Jun; 14(6):961-2. PubMed ID: 12796037
[No Abstract] [Full Text] [Related]
14. Acute, generalised but transient muscle cramping and weakness shortly after first oxaliplatin infusion.
Krexner E; Stickler A; Prainer C; Finsterer J
Med Oncol; 2012 Dec; 29(5):3592-3. PubMed ID: 22669568
[No Abstract] [Full Text] [Related]
15. Serious delayed hypersensitivity reaction to oxaliplatin.
de Vries RS; Mattijssen EJ; van Sorge AA
Ann Oncol; 2006 Nov; 17(11):1723-4. PubMed ID: 16757568
[No Abstract] [Full Text] [Related]
16. Oxaliplatin-induced haemolytic anaemia.
Desrame J; Broustet H; Darodes de Tailly P; Girard D; Saissy JM
Lancet; 1999 Oct; 354(9185):1179-80. PubMed ID: 10513718
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous administration of amifostine: a promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy.
Penz M; Kornek GV; Raderer M; Ulrich-Pur H; Fiebiger W; Scheithauer W
Ann Oncol; 2001 Mar; 12(3):421-2. PubMed ID: 11332158
[No Abstract] [Full Text] [Related]
18. Reaction after oxaliplatin--prevention with corticosteroids?
Stahl M; Köster W; Wilke H
Ann Oncol; 2001 Jun; 12(6):874. PubMed ID: 11484969
[No Abstract] [Full Text] [Related]
19. [Genetic backgrounds of peripheral neuropathy induced by oxaliplatin].
Mitsuma A; Ando Y
Nihon Yakurigaku Zasshi; 2013 Feb; 141(2):62-5. PubMed ID: 23391543
[No Abstract] [Full Text] [Related]
20. Idiosyncratic reaction after oxaliplatin: circumvention by use of a continuous infusional administration schedule.
Schüll B; Kornek GV; Scheithauer W
Ann Oncol; 2001 Nov; 12(11):1653-4. PubMed ID: 11822769
[No Abstract] [Full Text] [Related]
[Next] [New Search]
